Article Information
History
- March 7, 2022.
Article Versions
- You are currently viewing Version 1 of this article (March 7, 2022 - 19:19).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- David Gonzalez-Perez1,
- Satyajit Das2,
- Elliot Medina1,
- Daniel Antfolk1,
- Emily D. Egan3,
- Stephen C. Blacklow3,
- Paulo C. Rodriguez2 and
- Vincent C. Luca1,*
- 1Department of Drug Discovery, Moffitt Cancer Center, Tampa, FL 33602, USA
- 2Department of Immunology, Moffitt Cancer Center, Tampa, FL 33612, USA
- 3Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115; Department of Cancer Biology, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
- ↵*Corresponding author: vince.luca{at}moffitt.org